Number of the records: 1
Inhibition of cyclooxygenase-2 by meloxicam supports hematopoiesis
- 1.
SYSNO ASEP 0091750 Document Type A - Abstract R&D Document Type Není vybrán druh dokumentu Title Inhibition of cyclooxygenase-2 by meloxicam supports hematopoiesis Title Inhibice cyklooxygenázy-2 meloxicamem podporuje krvetvorbu Author(s) Štreitová, Denisa (BFU-R)
Hofer, Michal (BFU-R) RID, ORCID
Pospíšil, Milan (BFU-R)
Znojil, V. (CZ)
Holá, Jiřina (BFU-R)
Vacek, Antonín (BFU-R)Source Title Experimental Hematology. - : Elsevier - ISSN 0301-472X
Roč. 35, č. 9 (2007), P165Number of pages 1 s. Action 36th Annual Scientific Meeting of the ISEH - Society for Hematology and Stem Cells Event date 28.09.2007-30.09.2007 VEvent location Hamburg Country DE - Germany Event type EUR Language eng - English Country US - United States Keywords cyclooxygenase-2 ; meloxicam ; hematopoiesis Subject RIV BO - Biophysics R&D Projects 1QS500040507 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR) CEZ AV0Z50040507 - BFU-R (2005-2011) AV0Z50040702 - BFU-R (2007-2013) Annotation Meloxicam, a selective COX-2 inhibitor, whose therapeutic advantage is a low intensity and incidence of undesirable gastrointestinal side effects, supports hematopoiesis. The results suggest the promising possibility to use meloxicam as an auxiliary means reducing the high costs of G-CSF therapy of myelosuppression. Workplace Institute of Biophysics Contact Jana Poláková, polakova@ibp.cz, Tel.: 541 517 244 Year of Publishing 2008
Number of the records: 1